Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02255461
Title Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Pediatric Brain Tumor Consortium
Indications

central nervous system cancer

Therapies

Palbociclib

Age Groups: adult | child
Covered Countries USA

Additional content available in CKB BOOST